Member Info for Hypermarlin

@Nskno1 - it's a yes or no test, not a count.

@smp1 - this is it here https://find-and-update.company-information.service.gov.uk/company/06692081 the address on co house matches that on the synovate global website. Go to People tab and check them out, in addition to Meyer you'll also find e.g. Michael Hough, director of BHA https://find-and-update.company-information.service.gov.uk/officers/veR8OY6tXAWd0dYUTjnmmXZ13JM/appointments

Was called Onside Now for many years, till name change to Synovate 30/10/20. All on Companies House https://find-and-update.company-information.service.gov.uk/company/06692081

Synovate Global's website lists Guy Meyer as CEO, i.e. same CEO as Catenae.

@jmfw, it was re his house purchase https://www.lse.co.uk/rns/AVCT/directorpdmr-shareholding-nqtrvtnnba5kuvc.html

Indeed, not looking that good. I'm a recent joiner, but have now decided to take my funds elsewhere. Hello and goodbye peeps, good luck!

Anyone any theories as to why this is being taken down since lunchtime, did I miss some news or a shift in sentiment?

@liver - that's from June. History.

@Poundcake, indeed I do. My largest holding. Let's stick to AVCT shall, we, my 2nd largest.

@MFM, if you mean, some Director purchases would be helpful, I quite agree. However it appears that Sir Al does not have the dosh, as he's had to sell shares for his house, and I/we know zip about other directors. Maybe they are all impoverished.

....but I do see a relationship with the UK Govt prior information notice (as linked earlier this thread) for upping mass spec testing. £2m will however just buy a new set of screwdrivers and dust down the idle kit. OK, though, if it then gets the testing capacity ready for our BAMS products to be sold into that capacity.

ha ha replace the second string of *** with "d i r e c t o r s t a l k"

Replace the ***************** with *************interviews . com

Link https://www.***************************/avacta-group-make-significant-progress-with-its-highly-scalable-lateral-flow-test-interview/412940598

@Chengdo04 - exactly. I hope no-one still here thinks AVCT will be a direct beneficiary from the c£900m bid that's cooking right now....

Finncap text here:

https://researchlibrary.finncap.com/File/View?file=44c748bc-ea35-4033-9811-ecfcd67a6641

Avacta (AVCT): Corp
Positive progress report
Avacta remains on track to meet its key Q4 2020 milestones, namely (i) complete first pilot batch and carry out a clinical
evaluation of the professional use of SARS-CoV-2 rapid antigen test, (ii) clinical evaluation and partnership for the
BAMS™ SARS-CoV-2 test and (iii) UK regulatory filing for AVA6000 (pre|CISION™ chemotherapy). Confirmation that BBI
Solutions has developed a scalable manufacturing process for the SARS-CoV-2 antigen test with very good analytical
sensitivity, using laboratory samples of COVID-19, is a key milestone that de-risks this programme further. Near-term, we
expect data from clinical evaluations highlighting the sensitivity and specificity of the antigen test to be released, before
the final clinical validation, using final production batch tests, is undertaken. We maintain our target price of 310p (with a
range of 211-796p).

@Levs, what do you mean by "Sell on vaccine approval (if you can) and buy back after the crash? Wiser still maybe sell before the 10th dec just before the announcement?" What's happening on/after 10th December, please remind me?

Anyone? I can't remember if anyone worked out what these were for?

@Poundcake - borrowed time, as you say "precursor to a much larger clinical study" means Easter 2021 in my mind before anything of substance could be sold. BAMS excluded.

@Onassis - I've been here a long time, and think I know what's happening. Not clear, however, as to what it is that makes you think this might be 140+ by Friday. Could you be specific? What trigger do you think would come through for this?